Your browser doesn't support javascript.
loading
SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy.
Pegoraro, E; Hoffman, E P; Piva, L; Gavassini, B F; Cagnin, S; Ermani, M; Bello, L; Soraru, G; Pacchioni, B; Bonifati, M D; Lanfranchi, G; Angelini, C; Kesari, A; Lee, I; Gordish-Dressman, H; Devaney, J M; McDonald, C M.
Afiliación
  • Pegoraro E; Neuromuscular Center, Department of Neurosciences, University of Padova, 35128 Padova, Italy elena.pegoraro@unipd.it.
Neurology ; 76(3): 219-26, 2011 Jan 18.
Article en En | MEDLINE | ID: mdl-21178099
OBJECTIVE: Duchenne muscular dystrophy (DMD) is the most common single-gene lethal disorder. Substantial patient-patient variability in disease onset and progression and response to glucocorticoids is seen, suggesting genetic or environmental modifiers. METHODS: Two DMD cohorts were used as test and validation groups to define genetic modifiers: a Padova longitudinal cohort (n = 106) and the Cooperative International Neuromuscular Research Group (CINRG) cross-sectional natural history cohort (n = 156). Single nucleotide polymorphisms to be genotyped were selected from mRNA profiling in patients with severe vs mild DMD, and genome-wide association studies in metabolism and polymorphisms influencing muscle phenotypes in normal volunteers were studied. RESULTS: Effects on both disease progression and response to glucocorticoids were observed with polymorphism rs28357094 in the gene promoter of SPP1 (osteopontin). The G allele (dominant model; 35% of subjects) was associated with more rapid progression (Padova cohort log rank p = 0.003), and 12%-19% less grip strength (CINRG cohort p = 0.0003). CONCLUSIONS: Osteopontin genotype is a genetic modifier of disease severity in Duchenne dystrophy. Inclusion of genotype data as a covariate or in inclusion criteria in DMD clinical trials would reduce intersubject variance, and increase sensitivity of the trials, particularly in older subjects.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Distrofia Muscular de Duchenne / Polimorfismo de Nucleótido Simple / Osteopontina Tipo de estudio: Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Child / Child, preschool / Female / Humans / Male País/Región como asunto: Europa Idioma: En Revista: Neurology Año: 2011 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Distrofia Muscular de Duchenne / Polimorfismo de Nucleótido Simple / Osteopontina Tipo de estudio: Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Child / Child, preschool / Female / Humans / Male País/Región como asunto: Europa Idioma: En Revista: Neurology Año: 2011 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Estados Unidos